About: Compliance with osteoporosis drug therapy and risk of fracture

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Compliance with osteoporosis drug therapy and risk of fracture Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 October 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 2006 (uk) im Oktober 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'ochobre de 2006 (ast) scientific article published on 05 October 2006 (en)
publication date	wds:Q79190751-B4FB6135-FC80-4A7C-A2EA-A7FB9926DD58
publication date	2006-10-05 00:00:00Z (xsd:dateTime)
exact match	wds:Q79190751-A4EA2245-8225-4D34-A2A7-97CB0DA2F1ED
exact match	https://scigraph.springernature.com/pub.10.1007/s00198-006-0230-y
cites work	wds:Q79190751-14624EDD-1261-4E03-8BEF-373840600968 wds:Q79190751-19A5E168-4817-438B-B8B1-1695472DF2AB wds:Q79190751-1A3A05FB-2106-4D01-AB8B-10A49B0CA480 wds:Q79190751-2B51ED5F-D6F6-46FE-86D4-58B86D2DE702 wds:Q79190751-2E323338-B92E-4314-82AB-38FA7EDDC0EC wds:Q79190751-3C1CCF3A-D133-4C55-B350-5B9C370EE5CF wds:Q79190751-3EB27250-EC64-4EEF-A8A1-7457F3F4E72C wds:Q79190751-52A9881B-54DE-4B63-AEC7-F9B46EE29FF0 wds:Q79190751-5432E41F-669A-48F8-8EAD-EB5A747B0742 wds:Q79190751-55BC204A-752A-4111-A428-57F7135264DC wds:Q79190751-5961500A-A3B5-4327-967A-0475FEE6E57F wds:Q79190751-5AC6D2F4-2F54-47E4-B807-E86F7E47E972 wds:Q79190751-8A0B6A69-E858-4269-900D-2CE7575428EA wds:Q79190751-9EA42799-AF2C-4AC4-AC09-B82FD5691D73 wds:Q79190751-A74DCE57-AF61-4243-B4A0-E7B2497BE547 wds:Q79190751-C09798CA-66B3-4AFC-AB27-A9C972E93189 wds:Q79190751-E5571DB4-990A-4929-BEA1-E388074FF5E3 wds:Q79190751-F3669B38-E86B-4C23-8B8D-CFC0884368A2
cites work	Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial Postmenopausal hormonal support: discontinuation of raloxifene versus estrogen Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group Assessment of compliance with osteoporosis treatment and its consequences in a managed care population Older women with fractures: patients falling through the cracks of guideline-recommended osteoporosis screening and treatment. Adherence to Medication Estimating medication persistency using administrative claims data. Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation Treatment of osteoporosis: are physicians missing an opportunity? Compliance with drug therapies for the treatment and prevention of osteoporosis Low Frequency of Treatment of Osteoporosis Among Postmenopausal Women Following a Fracture Osteoporosis intervention following distal forearm fractures: a missed opportunity? Comparing Therapies for Postmenopausal Osteoporosis Prevention and Treatment
author name string	wds:Q79190751-9D887A7E-FDCD-4383-8F6D-518722B6CF85 wds:Q79190751-A96199DC-D960-411F-942B-4126C043B8AC wds:Q79190751-AC33BE8C-733F-4584-8984-6A1A5CBC5039 wds:Q79190751-C96A4114-753A-4DB6-ADC8-5592CF911714
author name string	D Macarios G Oster D Weycker J Edelsberg
rdfs:label	Compliance with osteoporosis drug therapy and risk of fracture (en) Compliance with osteoporosis drug therapy and risk of fracture (nl)
skos:prefLabel	Compliance with osteoporosis drug therapy and risk of fracture (en) Compliance with osteoporosis drug therapy and risk of fracture (nl)
name	Compliance with osteoporosis drug therapy and risk of fracture (en) Compliance with osteoporosis drug therapy and risk of fracture (nl)
title	wds:Q79190751-4D3474FC-B78B-4D1D-B1D1-918CCA345F67
title	Compliance with osteoporosis drug therapy and risk of fracture (en)
page(s)	wds:Q79190751-9EB285CD-27D7-4778-A689-2371940F59FE
page(s)	271-277
instance of	wds:Q79190751-02AA5203-282F-496C-8782-F0EC694C7045
instance of	scholarly article
main subject	wds:Q79190751-E7E31313-763C-41A7-9C87-1388F86B826D
main subject	bone fracture
PubMed ID	wds:Q79190751-426974B6-19DF-4CD4-BED5-57FB97F89FFB
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17021945
PubMed ID	17021945
published in	wds:Q79190751-1E88BE8C-6C94-4058-A0F9-ED442C8F10D2
published in	Osteoporosis International
issue	wds:Q79190751-7FA2CAFC-4D80-4470-BF46-97A10E803477
volume	wds:Q79190751-C71AFD9F-B890-4904-A267-A181F1FE6D40
issue	3
volume	18
DOI	wds:Q79190751-3D38802E-300D-455E-84BE-0D636116B021
DOI	http://dx.doi.org/10.1007/S00198-006-0230-Y
DOI	10.1007/S00198-006-0230-Y
Dimensions Publication ID	wds:Q79190751-E504FC8C-1741-486D-92B1-1A81E1D373D0
Dimensions Publication ID	1015112135
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79190751
is cites work of	Loss of treatment benefit due to low compliance with bisphosphonate therapy Incorporating adherence into health economic modelling of osteoporosis Protocol for the Osteoporosis Choice trial. A pilot randomized trial of a decision aid in primary care practice The association between compliance and persistence with bisphosphonate therapy and fracture risk: a review Impact of noncompliance with alendronate and risedronate on the incidence of nonvertebral osteoporotic fractures in elderly women Systematic review and meta-analysis of real-world adherence to drug therapy for osteoporosis Osteoporosis medication profile preference: results from the PREFER-US study The complex relation between bisphosphonate adherence and fracture reduction. The economics of improving medication adherence in osteoporosis: validation and application of a simulation model GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates Management of osteoporosis in fracture liaison service associated with long-term adherence to treatment Persistence with intravenous zoledronate in elderly patients with osteoporosis. The potential economic benefits of improved postfracture care: a cost-effectiveness analysis of a fracture liaison service in the US health-care system Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis Alendronate adherence and its impact on hip-fracture risk in patients with established osteoporosis in Taiwan Diagnosis and management of osteoporosis in the older senior The effect of dried plum on serum levels of receptor activator of NF-κB ligand, osteoprotegerin and sclerostin in osteopenic postmenopausal women: a randomised controlled trial

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software